Bruce Strober MD PhD

Clinical Professor, Dermatology, Yale University

1 Willowbrook RdSte 2Cromwell, CT 06416
Phone+1 860-322-2222
Fax+1 860-322-6838

Dr. Strober is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Strober's full profile Already have an account?

Education & Training

NYU Grossman School of MedicineResidency, Dermatology, 1999 - 2002
NYU Grossman School of MedicineInternship, Internal Medicine, 1998 - 1999
Columbia University Vagelos College of Physicians and SurgeonsClass of 1998
Columbia University Vagelos College of Physicians and SurgeonsPhD, Medical Scientist Training Program (MSTP), 1991 - 1996
Columbia UniversityPhD, Molecular Biology, 1991 - 1996

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 2000 - 2028
CT State Medical License 2011 - 2027
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa
COMPLETED
PHASE1
Use of KC706 for the Treatment of Pemphigus Vulgaris
COMPLETED
PHASE2

Publications & Presentations

PubMed

Effectiveness of brodalumab in biologic-experienced adults with moderate to severe plaque psoriasis: a focused narrative review.
April W Armstrong, Bruce E Strober, Clive M Liu, Jennifer C Cather, Joseph F Merola
The Journal of Dermatological Treatment. 2026-12-01
Rapid resolution of generalized pustular psoriasis with upadacitinib.
Sonam Mistry, Mark Marchitto, Bruce Strober
JAAD Case Reports. 2026-09-01
Characteristics of Real-World Patients with Psoriasis Receiving Guselkumab or Interleukin-17 Inhibitors: Data from the Psoriasis Longitudinal Assessment and Registry (...
Bruce Strober, Matthias Augustin, Yayoi Tada, Kimberly Parnell Lafferty, Yevgeniy Krol
Journal of Psoriasis and Psoriatic Arthritis. 2026-08-12

Journal Articles

Dose Response and Pharmacokinetics of Tofacitinib (CP-690,550), an Oral Janus Kinase Inhibitor, in the Treatment of Chronic Plaque Psoriasis
Tan H, Gupta P, Harness J, Wolk R, Chapel S, Menter A, Strober B, Langley RG, Krishnaswami S, Papp KA, CPT: Pharmacomet Syst Pharmacol, 1/1/2013

Books/Book Chapters

Fitzpatrick's Dermatology in General Medicine
Chapter: Chapter 220: "Topical and Intralesional Cytotoxic Agents"
Moore MM and Strober BEEditors: K. Wolff, et al..McGraw-Hill Companies, Inc., USAEdition 7th,2008
Fitzpatrick's Dermatology in General Medicine
Chapter: Chapter 214: "Principles of Topical Therapy"
Bergstrom KG, Strober BEEditors: K. Wolff, et al..McGraw-Hill Companies, Inc., USAEdition 7th,2008
Psoriasis and Psoriatic Arthritis: An Integrated Approach
Chapter: Chapter XA2: "TNF Antagonist Therapy"
Strober BEEditors: K.B. Gordon and E.M. Ruderman.Springer Berlin Heidelberg, New York2005

Abstracts/Posters

Psoriasis Patients with PASI90 Response Achieve Greater Health-related Quality of Life Improvements than Those with PASI75 Response
McLeod L, Mallya U, Fox T, Strober B, 23rd Congress of the EADV, Amsterdam, The Netherlands, 1/1/2014
Phase 2 Study of Brodalumab (AMG827) For Moderate-to-severe Plaque Psoriasis: Week 12 Results on Efficacy and Safety in Patients with Psoriatic Arthritis
Papp KA, Menter A, Ortonne J-P, Strober B, Kricorian G, Thompson EH, Milmont CE, Nirula A, Klekotka P, CDA 89th Annual Conference, Toronto, Ontario, Canada, 1/1/2014
Psoriasis Longitudinal Assessment and Registry (PSOLAR): Global Update of a Multicentre, Open Registry of Psoriasis Patients
Papp K, Augustin M, Ho V, Leonardi C, Menter A, Strober B, Calabro S, Langholff W, Fakharzadeh S, Chevrier M, CDA 89th Annual Conference, Toronto, Ontario, Canada, 1/1/2014

Lectures

Hand and Foot Psoriasis, Dermatitis, and Other Inflammatory Dermatoses
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019
Biologics Psoriasis Guidelines: Translating Evidence into Practice
Chicago, Illinois - 1/1/2014
Use of Biologics in Hidradenitis Suppurativa
Naples, Florida - 1/1/2014

Other

Core Outcome Sets for Psoriasis Clinical Trials
Bruce Strober, MD, JAMA
https://www.doximity.com/articles/8cc1a023-7261-4aa3-a153-dfbe3310e004
UpToDate, Wolters Kluwer Health - 2013-02-20

Press Mentions

Mindera Health™ Announces Publication of Randomized, Prospective Clinical Utility Study Demonstrating Improved Psoriasis Patient OutcomesMay 13th, 2025
Momentum for Oral Therapies to Treat Plaque PsoriasisApril 4th, 2025
Biologics for Psoriasis: Towards Oral Therapies and Less Frequent DosingAugust 13th, 2024